Transcatheter  ||| S:0 E:14 ||| FW
mitral  ||| S:14 E:21 ||| FW
valve  ||| S:21 E:27 ||| FW
interventions ||| S:27 E:40 ||| FW
:  ||| S:40 E:42 ||| :
current  ||| S:42 E:50 ||| JJ
status  ||| S:50 E:57 ||| NN
and  ||| S:57 E:61 ||| CC
future  ||| S:61 E:68 ||| JJ
perspective  ||| S:68 E:80 ||| NN
With  ||| S:80 E:85 ||| IN
the  ||| S:85 E:89 ||| DT
recent  ||| S:89 E:96 ||| JJ
developments  ||| S:96 E:109 ||| NNS
in  ||| S:109 E:112 ||| IN
the  ||| S:112 E:116 ||| DT
field  ||| S:116 E:122 ||| NN
of  ||| S:122 E:125 ||| IN
transcatheter  ||| S:125 E:139 ||| JJ
aortic  ||| S:139 E:146 ||| JJ
valve  ||| S:146 E:152 ||| JJ
replacement  ||| S:152 E:164 ||| NN
for  ||| S:164 E:168 ||| IN
aortic  ||| S:168 E:175 ||| NNS
stenosis  ||| S:175 E:184 ||| VBP
there  ||| S:184 E:190 ||| EX
has  ||| S:190 E:194 ||| VBZ
been  ||| S:194 E:199 ||| VBN
a  ||| S:199 E:201 ||| DT
similar  ||| S:201 E:209 ||| JJ
advance  ||| S:209 E:217 ||| NN
in  ||| S:217 E:220 ||| IN
the  ||| S:220 E:224 ||| DT
field  ||| S:224 E:230 ||| NN
of  ||| S:230 E:233 ||| IN
transcatheter  ||| S:233 E:247 ||| JJ
mitral  ||| S:247 E:254 ||| JJ
valve  ||| S:254 E:260 ||| JJ
therapy  ||| S:260 E:268 ||| NN
for  ||| S:268 E:272 ||| IN
mitral  ||| S:272 E:279 ||| JJ
regurgitation  ||| S:279 E:293 ||| NNS
( ||| S:293 E:294 ||| -LRB-
MR ||| S:294 E:296 ||| NNP
) ||| S:296 E:297 ||| -RRB-
.  ||| S:297 E:299 ||| .
Both  ||| S:299 E:304 ||| PDT
the  ||| S:304 E:308 ||| DT
anatomy  ||| S:308 E:316 ||| NN
of  ||| S:316 E:319 ||| IN
the  ||| S:319 E:323 ||| DT
mitral  ||| S:323 E:330 ||| JJ
apparatus  ||| S:330 E:340 ||| NN
and  ||| S:340 E:344 ||| CC
the  ||| S:344 E:348 ||| DT
spectrum  ||| S:348 E:357 ||| NN
of  ||| S:357 E:360 ||| IN
pathology  ||| S:360 E:370 ||| NN
of  ||| S:370 E:373 ||| IN
MR  ||| S:373 E:376 ||| NNP
are  ||| S:376 E:380 ||| VBP
more  ||| S:380 E:385 ||| RBR
complex  ||| S:385 E:393 ||| JJ
than  ||| S:393 E:398 ||| IN
for  ||| S:398 E:402 ||| IN
aortic  ||| S:402 E:409 ||| JJ
valve  ||| S:409 E:415 ||| JJ
disease ||| S:415 E:422 ||| NN
,  ||| S:422 E:424 ||| ,
and  ||| S:424 E:428 ||| CC
thus  ||| S:428 E:433 ||| RB
the  ||| S:433 E:437 ||| DT
development  ||| S:437 E:449 ||| NN
of  ||| S:449 E:452 ||| IN
MR  ||| S:452 E:455 ||| NNP
therapies  ||| S:455 E:465 ||| NN
has  ||| S:465 E:469 ||| VBZ
been  ||| S:469 E:474 ||| VBN
more  ||| S:474 E:479 ||| RBR
complicated  ||| S:479 E:491 ||| JJ
and  ||| S:491 E:495 ||| CC
less  ||| S:495 E:500 ||| RBR
rapid ||| S:500 E:505 ||| JJ
.  ||| S:505 E:507 ||| .
The  ||| S:507 E:511 ||| DT
purpose  ||| S:511 E:519 ||| NN
of  ||| S:519 E:522 ||| IN
this  ||| S:522 E:527 ||| DT
review  ||| S:527 E:534 ||| NN
of  ||| S:534 E:537 ||| IN
recent  ||| S:537 E:544 ||| JJ
literature  ||| S:544 E:555 ||| NN
is  ||| S:555 E:558 ||| VBZ
to  ||| S:558 E:561 ||| TO
provide  ||| S:561 E:569 ||| VB
a  ||| S:569 E:571 ||| DT
synopsis  ||| S:571 E:580 ||| NN
of  ||| S:580 E:583 ||| IN
the  ||| S:583 E:587 ||| DT
present  ||| S:587 E:595 ||| JJ
technologies  ||| S:595 E:608 ||| NNS
under  ||| S:608 E:614 ||| IN
development  ||| S:614 E:626 ||| NN
for  ||| S:626 E:630 ||| IN
percutaneous  ||| S:630 E:643 ||| JJ
therapy  ||| S:643 E:651 ||| NN
for  ||| S:651 E:655 ||| IN
MR ||| S:655 E:657 ||| NNP
.  ||| S:657 E:659 ||| .
Leaflet  ||| S:659 E:667 ||| JJ
repair  ||| S:667 E:674 ||| NN
with  ||| S:674 E:679 ||| IN
MitraClip  ||| S:679 E:689 ||| NNP
has  ||| S:689 E:693 ||| VBZ
accrued  ||| S:693 E:701 ||| VBN
the  ||| S:701 E:705 ||| DT
largest  ||| S:705 E:713 ||| JJS
human  ||| S:713 E:719 ||| JJ
experience  ||| S:719 E:730 ||| NN
among  ||| S:730 E:736 ||| IN
the  ||| S:736 E:740 ||| DT
technologies  ||| S:740 E:753 ||| NNS
that  ||| S:753 E:758 ||| WDT
are  ||| S:758 E:762 ||| VBP
under  ||| S:762 E:768 ||| IN
development ||| S:768 E:779 ||| NN
,  ||| S:779 E:781 ||| ,
having  ||| S:781 E:788 ||| VBG
been  ||| S:788 E:793 ||| VBN
used  ||| S:793 E:798 ||| VBN
to  ||| S:798 E:801 ||| TO
treat  ||| S:801 E:807 ||| VB
over  ||| S:807 E:812 ||| IN
6,000  ||| S:812 E:818 ||| CD
patients ||| S:818 E:826 ||| NNS
.  ||| S:826 E:828 ||| .
MitraClip  ||| S:828 E:838 ||| NNP
is  ||| S:838 E:841 ||| VBZ
currently  ||| S:841 E:851 ||| RB
being  ||| S:851 E:857 ||| VBG
used  ||| S:857 E:862 ||| VBN
in  ||| S:862 E:865 ||| IN
patients  ||| S:865 E:874 ||| NNS
with  ||| S:874 E:879 ||| IN
functional  ||| S:879 E:890 ||| JJ
MR  ||| S:890 E:893 ||| NNP
and  ||| S:893 E:897 ||| CC
at  ||| S:897 E:900 ||| IN
high  ||| S:900 E:905 ||| JJ
risk  ||| S:905 E:910 ||| NN
for  ||| S:910 E:914 ||| IN
conventional  ||| S:914 E:927 ||| JJ
surgery ||| S:927 E:934 ||| NN
.  ||| S:934 E:936 ||| .
Coronary  ||| S:936 E:945 ||| JJ
sinus ||| S:945 E:950 ||| NN
,  ||| S:950 E:952 ||| ,
or  ||| S:952 E:955 ||| CC
indirect  ||| S:955 E:964 ||| JJ
annuloplasty ||| S:964 E:976 ||| NN
,  ||| S:976 E:978 ||| ,
has  ||| S:978 E:982 ||| VBZ
the  ||| S:982 E:986 ||| DT
next  ||| S:986 E:991 ||| JJ
largest  ||| S:991 E:999 ||| JJS
clinical  ||| S:999 E:1008 ||| JJ
experience ||| S:1008 E:1018 ||| NN
,  ||| S:1018 E:1020 ||| ,
with  ||| S:1020 E:1025 ||| IN
several  ||| S:1025 E:1033 ||| JJ
hundred  ||| S:1033 E:1041 ||| CD
patients  ||| S:1041 E:1050 ||| NNS
treated  ||| S:1050 E:1058 ||| VBN
in  ||| S:1058 E:1061 ||| IN
trials ||| S:1061 E:1067 ||| NNS
.  ||| S:1067 E:1069 ||| .
Other  ||| S:1069 E:1075 ||| JJ
MR  ||| S:1075 E:1078 ||| NNP
therapy  ||| S:1078 E:1086 ||| NN
devices ||| S:1086 E:1093 ||| NNS
,  ||| S:1093 E:1095 ||| ,
including  ||| S:1095 E:1105 ||| VBG
several  ||| S:1105 E:1113 ||| JJ
direct  ||| S:1113 E:1120 ||| JJ
annuloplasty  ||| S:1120 E:1133 ||| JJ
approaches ||| S:1133 E:1143 ||| NNS
,  ||| S:1143 E:1145 ||| ,
mitral  ||| S:1145 E:1152 ||| FW
valve  ||| S:1152 E:1158 ||| FW
replacement  ||| S:1158 E:1170 ||| FW
prostheses ||| S:1170 E:1180 ||| FW
,  ||| S:1180 E:1182 ||| ,
and  ||| S:1182 E:1186 ||| CC
chordal  ||| S:1186 E:1194 ||| JJ
replacement  ||| S:1194 E:1206 ||| NN
devices ||| S:1206 E:1213 ||| NNS
,  ||| S:1213 E:1215 ||| ,
are  ||| S:1215 E:1219 ||| VBP
still  ||| S:1219 E:1225 ||| RB
in  ||| S:1225 E:1228 ||| IN
the  ||| S:1228 E:1232 ||| DT
earlier  ||| S:1232 E:1240 ||| JJR
phases  ||| S:1240 E:1247 ||| NNS
of  ||| S:1247 E:1250 ||| IN
development ||| S:1250 E:1261 ||| NN
.  ||| S:1261 E:1263 ||| .
The  ||| S:1263 E:1267 ||| DT
early  ||| S:1267 E:1273 ||| JJ
technological  ||| S:1273 E:1287 ||| JJ
advances  ||| S:1287 E:1296 ||| NNS
have  ||| S:1296 E:1301 ||| VBP
not  ||| S:1301 E:1305 ||| RB
only  ||| S:1305 E:1310 ||| RB
enhanced  ||| S:1310 E:1319 ||| VBN
our  ||| S:1319 E:1323 ||| PRP$
understanding  ||| S:1323 E:1337 ||| NN
of  ||| S:1337 E:1340 ||| IN
the  ||| S:1340 E:1344 ||| DT
complex  ||| S:1344 E:1352 ||| JJ
interplay  ||| S:1352 E:1362 ||| NN
of  ||| S:1362 E:1365 ||| IN
different  ||| S:1365 E:1375 ||| JJ
components  ||| S:1375 E:1386 ||| NNS
of  ||| S:1386 E:1389 ||| IN
the  ||| S:1389 E:1393 ||| DT
mitral  ||| S:1393 E:1400 ||| JJ
valve  ||| S:1400 E:1406 ||| JJ
apparatus  ||| S:1406 E:1416 ||| NN
but  ||| S:1416 E:1420 ||| CC
also  ||| S:1420 E:1425 ||| RB
promise  ||| S:1425 E:1433 ||| VBP
continued  ||| S:1433 E:1443 ||| VBN
refinement  ||| S:1443 E:1454 ||| VBN
in  ||| S:1454 E:1457 ||| IN
our  ||| S:1457 E:1461 ||| PRP$
present  ||| S:1461 E:1469 ||| JJ
modalities  ||| S:1469 E:1480 ||| NN
of  ||| S:1480 E:1483 ||| IN
treatment  ||| S:1483 E:1493 ||| NN
and  ||| S:1493 E:1497 ||| CC
improved  ||| S:1497 E:1506 ||| JJ
clinical  ||| S:1506 E:1515 ||| JJ
outcomes  ||| S:1515 E:1524 ||| NNS
for  ||| S:1524 E:1528 ||| IN
future  ||| S:1528 E:1535 ||| JJ
patients ||| S:1535 E:1543 ||| NNS
.  ||| S:1543 E:1545 ||| .
